Pharmacokinetic Allometric Scaling of Antibodies: Application to the First-In-Human Dose Estimation
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 98 (10) , 3850-3861
- https://doi.org/10.1002/jps.21682
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Predicting Oral Clearance in HumansClinical Pharmacokinetics, 2008
- Prediction of human drug clearance from animal data: Application of the rule of exponents and ‘fu corrected intercept method’ (FCIM)Journal of Pharmaceutical Sciences, 2006
- A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALINGDrug Metabolism and Disposition, 2005
- Interspecies Scaling of Biliary Excreted Drugs: A Comparison of Several MethodsJournal of Pharmaceutical Sciences, 2005
- Selection of the First‐Time Dose in Humans: Comparison of Different Approaches Based on Interspecies Scaling of ClearanceThe Journal of Clinical Pharmacology, 2003
- Interspecies scaling of renally secreted drugsLife Sciences, 1998
- Integration of in Vitro Data into Allometric Scaling to Predict Hepatic Metabolic Clearance in Man: Application to 10 Extensively Metabolized DrugsJournal of Pharmaceutical Sciences, 1997
- Interspecies scaling: predicting clearance of drugs in humans. Three different approachesXenobiotica, 1996
- First‐Time‐in‐Human Dose Selection: Allometric Thoughts and PerspectivesThe Journal of Clinical Pharmacology, 1995
- Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian speciesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1984